读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
丽珠医药集团股份有限公司2012年第一季度报告全文(英文版) 下载公告
公告日期:2012-04-21
Full text f the 2012 First Quarterly Report of Livzon Pharmaceutical Group Inc.
      Full Text of the 2012 First Quarterly Report of Livzon Pharmaceutical Group Inc.
§1 Important notice
1.1 The Board of Directors (BOD), Board of Supervisors (BOS), directors, supervisors, and senior
executives hereby guarantee that the data in the present report contain no false representation,
misleading statements and serious omissions, and shall be severally and jointly liable for the
authenticity, accuracy and completeness of the content.
1.2 The first quarterly report has not been audited by any accountants firms.
1.3 Mr. Zhu Baoguo, principal of the Company, Mr. An Ning, the principal in charge of accounting, and
Ms. Si Yanxia, the principal of the Accounting Department hereby declare: We guarantee the
authenticity and completeness of the Financial Report in this quarterly report.
§2 Brief introduction of the Company
2.1 Financial highlights
                                                                                                                 Unit: RMB Yuan
                                                               End of this report          End of previous        Increase or
                                                                    period                      Year             decrease (%)
                 Total assets (RMB Yuan)                         4,554,878,274.85          4,602,908,981.74              -1.04%
    Owners’ equity attributable to the shareholders of
                                                                 2,959,205,752.55          2,843,169,706.20               4.08%
              listed company (RMB Yuan)
                Total share capital (share)                         295,721,852.00           295,721,852.00               0.00%
         Net assets per share attributable to the
                                                                                  10.01                  9.61             4.16%
    shareholders of listed company (RMB Yuan/share)
                                                               End of this report          Same period in         Increase or
                                                                    period                  previous year        decrease (%)
           Total operating income (RMB Yuan)                        892,862,698.79           749,385,019.01              19.15%
    Net profit attributable to the shareholders of listed
                                                                    117,291,231.12           125,815,417.35              -6.78%
                    company (RMB Yuan)
      Net cash flows from operating activities (RMB
                                                                    133,979,956.38           118,304,818.20              13.25%
                         Yuan)
    Net cash flows per share from operating activities
                                                                                   0.45                  0.40            12.50%
                   (RMB Yuan/share)
         Basic profit per share (RMB Yuan/share)                                   0.40                  0.43            -6.98%
    Diluted profit per share (RMB Yuan/share)                                  0.40                  0.43            -6.98%
      Weighed average yield rate of net assets (%)                            4.04%                    4.88%             -0.84%
      Weighed average yield rate of net assets after
                                                                              3.78%                    4.46%             -0.68%
      deduction of non-recurring profit and loss (%)
Items of non-recurring profit and loss
√ Applicable □ Inapplicable
                                                                                                                 Unit: RMB Yuan
                                                     

  附件:公告原文
返回页顶